@misc{indiciaef09e65e6c840,
  title = {Preclinical efficacy, safety, and immunogenicity of PHH-1V, a second-generation COVID-19 vaccine candidate based on a novel recombinant RBD fusion heterodimer of SARS-CoV-2.},
  author = {Barreiro, A. and Prenafeta, A. and Bech-Sabat, G. and Roca, M. and March, R. and Gonzalez, L. and Madrenas, L. and Corominas, J. and Fernandez, A. and Molas, M. and Vergara-Alert, J. and Lorca-Oro, C. and Roca, N. and Fernandez-Bastit, L. and Rodon, J. and Perez, M. and Segales, J. and Pradenas, E. and Marfil, S. and Trinite, B. and Ortiz, R. and Clotet, B. and Blanco, J. and Diaz Pedroza, J. and Ampudia Carrasco, R. and Rosales Salgado, Y. and Loubat Casanovas, J. and Capdevila Larripa, S. and Garcia Prado, J. and Barretina Ginesta, J. and Sistere-Oro, M. and Cebollada Rica, P. and Meyerhans, A. and Ferrer, L. and Torroella, E.},
  year = {2021},
  doi = {10.1101/2021.11.22.469117},
  url = {https://www.biorxiv.org/content/10.1101/2021.11.22.469117v1},
  note = {Source identifier: 10.1101/2021.11.22.469117}
}